Phase I FOLFOX Combination

• Status: Completed
• Trial end date: 2008-04-01

Summary

A Phase I,open label study to assess the safety and tolerability of ZD6474 in combination with 5-Fluorouracil, Leucovorin and Oxaliplatin (mFOLFOX6) as first and second line therapy in patients with advanced colorectal adenocarcinoma.

• Phase: Phase 1

Details

• Lead Sponsor: Genzyme, a Sanofi Company
• Treatments: Fluorouracil; Leucovorin; Oxaliplatin